MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

2015 Nature Reviews Neurology 406 citations

Abstract

The clinical use of MRI in patients with multiple sclerosis (MS) has advanced markedly over the past few years. Technical improvements and continuously emerging data from clinical trials and observational studies have contributed to the enhanced performance of this tool for achieving a prompt diagnosis in patients with MS. The aim of this article is to provide guidelines for the implementation of MRI of the brain and spinal cord in the diagnosis of patients who are suspected of having MS. These guidelines are based on an extensive review of the recent literature, as well as on the personal experience of the members of the MAGNIMS (Magnetic Resonance Imaging in MS) network. We address the indications, timing, coverage, reporting and interpretation of MRI studies in patients with suspected MS. Our recommendations are intended to help radiologists and neurologists standardize and optimize the use of MRI in clinical practice for the diagnosis of MS.

Keywords

MedicineMultiple sclerosisObservational studyMagnetic resonance imagingClinical PracticeMedical physicsClinical trialMEDLINERadiologyPhysical therapyPathologyPsychiatry

Affiliated Institutions

Related Publications

Publication Info

Year
2015
Type
review
Volume
11
Issue
8
Pages
471-482
Citations
406
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

406
OpenAlex

Cite This

Àlex Rovira, Mike P. Wattjes, Mar Tintoré et al. (2015). MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process. Nature Reviews Neurology , 11 (8) , 471-482. https://doi.org/10.1038/nrneurol.2015.106

Identifiers

DOI
10.1038/nrneurol.2015.106